Opus Genetics IRD
NASDAQ IRD
$4.01 +0.19 (+4.97%)
At close: Oct 20, 2026 · 4:00 PM EDT

Opus Genetics (IRD) Non-Current Debt (2025 - 2026)

Updated

Opus Genetics' Non-Current Debt came in at $34.93 million for Q2 2026, compared with $1 million a year earlier.

Analysis

Opus Genetics (IRD) Non-Current Debt (2025 - 2026) Analysis & Trends

At the end of FY2025, Opus Genetics' Non-Current Debt was $1.13 million.

  • Business Quant data shows IRD's Non-Current Debt at $1.2 million (Q1 2026), $1.13 million (Q4 2025) and $1.07 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 37.34 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 62.48 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 23.68 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 23.83 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 60.50 Bn
10 Opus Genetics 381.93 Mn 157.22 Mn - 34.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 34.93 Mn
Mar 31, 2026 1.20 Mn
Dec 31, 2025 1.13 Mn
Sep 30, 2025 1.07 Mn
Jun 30, 2025 1.00 Mn
API Access

Opus Genetics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=IRD&period=max&api_key=YOUR_API_KEY